Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery.

Standard

Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery. / Base, Eva M; Standl, Thomas; Lassnigg, Andrea; Skhirtladze, Keso; Jungheinrich, Cornelius; Gayko, Daniela; Hiesmayr, Michael.

In: J CARDIOTHOR VASC AN, Vol. 25, No. 3, 3, 2011, p. 407-414.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Base, EM, Standl, T, Lassnigg, A, Skhirtladze, K, Jungheinrich, C, Gayko, D & Hiesmayr, M 2011, 'Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery.', J CARDIOTHOR VASC AN, vol. 25, no. 3, 3, pp. 407-414. <http://www.ncbi.nlm.nih.gov/pubmed/21345699?dopt=Citation>

APA

Vancouver

Base EM, Standl T, Lassnigg A, Skhirtladze K, Jungheinrich C, Gayko D et al. Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery. J CARDIOTHOR VASC AN. 2011;25(3):407-414. 3.

Bibtex

@article{e643119f084a4262b0a2830a9d8009c4,
title = "Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery.",
abstract = "OBJECTIVE: The infusion of large amounts of saline-based solutions may contribute to the development of hyperchloremic metabolic acidosis and the use of a balanced carrier for colloid solutions might improve postoperative acid-base status. The equivalence of 2 hydroxyethyl starch (HES) solutions and the influence on chloride levels and acid-base status by selectively changing the carrier of rapidly degradable modern 6% HES 130/0.4 were studied in cardiac surgery patients. DESIGN: A prospective, randomized, double-blinded study. SETTING: A clinical study in 2 cardiac surgery institutions. PARTICIPANTS: Eighty-one patients. INTERVENTION: Patients received either 6% HES130/0.4 balanced (Volulyte; Fresenius Kabi, Bad Homburg, Germany) or 6% HES130/0.4 saline (Voluven; Fresenius Kabi, Bad Homburg, Germany) for intra- and postoperative hemodynamic stabilization. MEASUREMENTS AND MAIN RESULTS: The therapeutic equivalence of both HES formulations regarding volume effect and consecutively superiority of the balanced electrolyte solution regarding serum chloride levels and acid-base status were measured. Similar volumes of both HES 130/0.4 balanced and HES 130/0.4 saline were administered until 6 hours after surgery, 2,391 ± 518 mL in the HES 130/0.4 balanced group versus 2,241 ± 512 mL in the HES 130/0.4 saline group. The 95% confidence interval for the difference between treatments (-77; 377 mL; mean, 150 mL) was contained entirely in the predefined interval (-500, 500 mL), thereby proving equivalence. The serum chloride level (mmol/L) was lower (p <0.05 at the end of surgery), and arterial pH was higher in the balanced group at all time points except baseline, and base excess was less negative at all time points after baseline (p <0.01). CONCLUSIONS: Volumes of HES needed for hemodynamic stabilization were equivalent between treatment groups. Significantly lower serum chloride levels in the HES balanced group reflected the lower chloride load of similar infusion volumes. The HES balanced group had significantly less acidosis.",
author = "Base, {Eva M} and Thomas Standl and Andrea Lassnigg and Keso Skhirtladze and Cornelius Jungheinrich and Daniela Gayko and Michael Hiesmayr",
year = "2011",
language = "Deutsch",
volume = "25",
pages = "407--414",
journal = "J CARDIOTHOR VASC AN",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery.

AU - Base, Eva M

AU - Standl, Thomas

AU - Lassnigg, Andrea

AU - Skhirtladze, Keso

AU - Jungheinrich, Cornelius

AU - Gayko, Daniela

AU - Hiesmayr, Michael

PY - 2011

Y1 - 2011

N2 - OBJECTIVE: The infusion of large amounts of saline-based solutions may contribute to the development of hyperchloremic metabolic acidosis and the use of a balanced carrier for colloid solutions might improve postoperative acid-base status. The equivalence of 2 hydroxyethyl starch (HES) solutions and the influence on chloride levels and acid-base status by selectively changing the carrier of rapidly degradable modern 6% HES 130/0.4 were studied in cardiac surgery patients. DESIGN: A prospective, randomized, double-blinded study. SETTING: A clinical study in 2 cardiac surgery institutions. PARTICIPANTS: Eighty-one patients. INTERVENTION: Patients received either 6% HES130/0.4 balanced (Volulyte; Fresenius Kabi, Bad Homburg, Germany) or 6% HES130/0.4 saline (Voluven; Fresenius Kabi, Bad Homburg, Germany) for intra- and postoperative hemodynamic stabilization. MEASUREMENTS AND MAIN RESULTS: The therapeutic equivalence of both HES formulations regarding volume effect and consecutively superiority of the balanced electrolyte solution regarding serum chloride levels and acid-base status were measured. Similar volumes of both HES 130/0.4 balanced and HES 130/0.4 saline were administered until 6 hours after surgery, 2,391 ± 518 mL in the HES 130/0.4 balanced group versus 2,241 ± 512 mL in the HES 130/0.4 saline group. The 95% confidence interval for the difference between treatments (-77; 377 mL; mean, 150 mL) was contained entirely in the predefined interval (-500, 500 mL), thereby proving equivalence. The serum chloride level (mmol/L) was lower (p <0.05 at the end of surgery), and arterial pH was higher in the balanced group at all time points except baseline, and base excess was less negative at all time points after baseline (p <0.01). CONCLUSIONS: Volumes of HES needed for hemodynamic stabilization were equivalent between treatment groups. Significantly lower serum chloride levels in the HES balanced group reflected the lower chloride load of similar infusion volumes. The HES balanced group had significantly less acidosis.

AB - OBJECTIVE: The infusion of large amounts of saline-based solutions may contribute to the development of hyperchloremic metabolic acidosis and the use of a balanced carrier for colloid solutions might improve postoperative acid-base status. The equivalence of 2 hydroxyethyl starch (HES) solutions and the influence on chloride levels and acid-base status by selectively changing the carrier of rapidly degradable modern 6% HES 130/0.4 were studied in cardiac surgery patients. DESIGN: A prospective, randomized, double-blinded study. SETTING: A clinical study in 2 cardiac surgery institutions. PARTICIPANTS: Eighty-one patients. INTERVENTION: Patients received either 6% HES130/0.4 balanced (Volulyte; Fresenius Kabi, Bad Homburg, Germany) or 6% HES130/0.4 saline (Voluven; Fresenius Kabi, Bad Homburg, Germany) for intra- and postoperative hemodynamic stabilization. MEASUREMENTS AND MAIN RESULTS: The therapeutic equivalence of both HES formulations regarding volume effect and consecutively superiority of the balanced electrolyte solution regarding serum chloride levels and acid-base status were measured. Similar volumes of both HES 130/0.4 balanced and HES 130/0.4 saline were administered until 6 hours after surgery, 2,391 ± 518 mL in the HES 130/0.4 balanced group versus 2,241 ± 512 mL in the HES 130/0.4 saline group. The 95% confidence interval for the difference between treatments (-77; 377 mL; mean, 150 mL) was contained entirely in the predefined interval (-500, 500 mL), thereby proving equivalence. The serum chloride level (mmol/L) was lower (p <0.05 at the end of surgery), and arterial pH was higher in the balanced group at all time points except baseline, and base excess was less negative at all time points after baseline (p <0.01). CONCLUSIONS: Volumes of HES needed for hemodynamic stabilization were equivalent between treatment groups. Significantly lower serum chloride levels in the HES balanced group reflected the lower chloride load of similar infusion volumes. The HES balanced group had significantly less acidosis.

M3 - SCORING: Zeitschriftenaufsatz

VL - 25

SP - 407

EP - 414

JO - J CARDIOTHOR VASC AN

JF - J CARDIOTHOR VASC AN

SN - 1053-0770

IS - 3

M1 - 3

ER -